MICROLIFE HOME AFIB
SKU : 1ZIN04

Description

World’s First Blood Pressure Monitors that can Detect Atrial Fibrillation (AF) & Validated for use in Pregnancy- Pre-eclampsia & End Stage Renal Disease (ERD)

The WatchBP Home A is a WatchBP Home device equipped with an atrial fibrillation detection system. When you are diagnosed with hypertensive and/or having atrial fibrillation the WatchBP Home A(fib) is the best tool to optimize your treatment. When you have atrial fibrillation a physician can decide to prescribe you anti-arrhythmic drugs. These drugs should stop the atrial fibrillation. With the WatchBP home A you can easily verify the working of these drugs, while at the same time monitoring your blood pressure.

The National Institute for Health and Clinical Excellence (NICE) officially recommends using the WatchBP Home A during routine blood pressure measurement for all GP’s in the United Kingdom.

WatchBP monitors with implemented Afib detection system allow patients to be screened for Afib during blood pressure measurement. The Afib detection system has convincingly proven its accuracy, and showed that it leads to increased detection of new patients with Afib when used in general clinical practice. WatchBP Afib detects atrial fibrillation with high accuracy (sensitivity 97-100% – specificity 89%) as demonstrated in multiple comparative studies with ECG.

 

Features

* Screening for AFIB with high accuracy (at 97%~100% sensitivity and 89% specificity) while measuring blood pressure.

* Easy and convenient to use.

* Embedded ESH/AHA measurement guidelines lead to accurate home measurement data physicians can trust.

* Automated data tabulation displays averages for morning, evening and overall measurement.

* Recommended by leading medical societies.

Convenient

* Diagnostic mode- 7-day self-measurement program that strictly follows ESH/ AHA protocols

* Usual mode- Memory for 250 measurements and displays the average

* PC Connectivity- Transmit BP measurement data to any PC via USB connectivity

 

4 Steps for long-term monitoring of blood pressure or treatment verification:

Step 1: Patients take duplicate measurements once a week using the Usual mode. Measurements are automatically stored.

Step 2: Before each office visit duplicate morning and evening measurements are taken on 3 to 7 days using the Diagnostic mode.

Step 3: Home measurements of the WatchBP Home can be compared with office measurements.

Step 4: Patient’s blood pressure and response to treatment can be checked and confirmed.

In Practice

WatchBP home plays a valuable role in the long-term observation and management of controlled hypertensive patients.

In-between office visits, patients can take a single duplicate measurement once per week using the “Usual” mode. One week prior to the next office visit, patients can use the “Diagnostic” mode to collect measurements for 7 days as prescribed by the ESH/AHA guidelines. The WatchBP home device with the stored data should then be shown to the physician at the next office visit. The home-measured data in either “Diagnostic” or “Usual” mode can then be directly compared with the office measurements.

 

For patients with end stage renal disease

Patients with moderate to severe renal disease have a very high incidence of hypertension, paired with stiff (calcified) arteries. As automated measurements can be influenced by stiff arteries, a special validation is required before blood pressure monitors can be recommended for use among patients with end stage renal disease.

 

Accurate for use in pregnancy and pre-eclampsia

Pre-eclampsia is defined as new hypertension and substantial proteinuria after 20 weeks gestation. Due to the unpredictable nature of pre-eclampsia hypertensive women must have their blood pressure measured frequently.

Most oscillometric blood pressure monitors underestimate blood pressure in pre-eclampsia. For this reason, oscillometric blood pressure monitors may only be recommended for use in pregnancy when specifically tested in this special patient group. The WatchBP Home allows pregnant women to measure their blood pressure at home which could reduce the number of hospital visits and may help to make motherhood safer.

 

Peripheral Arterial Disease (PAD)

50% of all patients have no symptoms

Peripheral arterial disease (PAD) is an important, frequently occurring, cardiovascular risk factor that often remains undetected for too long. Patients with PAD have a three-fold higher risk of myocardial infarction, stroke and death. A recommended test for diagnosing PAD is performing ankle-arm measurements to assess the ankle brachial index (ABI). In general clinical practice ABI is often determined with a Doppler device. However, this method is time consuming and requires skills from the observer and therefore is not performed as well and as frequently as it should.

 

Early detection of atrial fibrillation can reduce the risk of a stroke by 68%

Atrial fibrillation (Afib)

Afib is the most common sustained cardiac arrhythmia occurring in 5% of the population of 65 years and above and in 14% among those older than 85 years. Afib leads to a 5-fold higher risk of stroke and is responsible for 20% of all strokes. Many people have no symptoms from Afib and therefore remain undiagnosed, whereas early treatment can reduce the risk of stroke by 68%.

WatchBP monitors with implemented Afib detection system allow patients to be screened for Afib during blood pressure measurement. The Afib detection system has convincingly proven its accuracy, and showed that it leads to increased detection of new patients with Afib when used in general clinical practice.

Recommended by NICE

The national institute for health and Clinical Excellence (NICE) officially recommends using the Watch BP Home A during routine blood pressure measurement for all GP’s in the United Kingdom.

www.nice.org.uk/MTG13

Technical Specifications

Operating temp: 10 – 40 °C / 50 – 104 °F

Storage temp: -20 – +50 °C / -4 – +122 °F, 15 – 90 % relative maximum humidity

Weight: 385 g (including batteries)

Dimensions: 150 x 100 x 50 mm

Measuring procedure: Oscillometric, corresponding to Korotkoff

Method: Phase I systolic, Phase V diastolic

Measurement range: 30 – 280 mmHg – blood pressure, 40 – 200 beats per minute – pulse

Cuff pressure display: Range: 0 – 299 mmHg, Resolution: 1 mmHg

Static accuracy: pressure within +/- 3 mmHg

Pulse accuracy: +/- 5 % of the readout value

Voltage source: 4 x 1.5 V Batteries: size AA

Main adapter: DC 6V, 600 mA (optional)

Reference to standards:

Device corresponds to the requirements of the standard for non-invasive blood pressure monitor:

* EN 1060-1

* EN 1060-3

* EN 1060-4

* IEC 60601-1

* IEC 60601-1-2